Virtual 39th Annual J.P. Morgan Healthcare Conference - Ichnos Sciences

Date: 01/15/2021

Category: Updates

Virtual 39th Annual J.P. Morgan Healthcare Conference

January 14, 2021 at 3:45 PM EST

Download the presentation deck

Recent updates

Ichnos Sciences Presents Preclinical Data Confirming Potential for ISB 1342 in Relapsed/Refractory Multiple Myeloma at 2021 ASCO Annual Meeting. Read more
May 2021 Update . Read more
Chief Executive Officer Alessandro Riva, M.D., to Leave Ichnos Sciences. Read more
Ichnos Sciences Presents Positive Data from Ongoing Phase 2b Study of Telazorlimab in Atopic Dermatitis at the 2021 SID Virtual Meeting. Read more
Ichnos Sciences Appoints Cyril Konto, M.D., Chief Medical Officer. Read more

View all updates

Concerning Your Privacy

Access to an Ichnos Site may be monitored by Ichnos. If monitored, the requesting URLs, the machine originating the request and the time of the request are logged for access statistics and security purposes. Your use and access of an Ichnos Site constitutes your consent to such general monitoring. Please see the Ichnos Privacy Policy and Cookie Notice for details on how information from the Site may be gathered and used.